Clinical Trial Update: Safety Study of XT-150 in Participants With ALS [Phase 1]

View source ↗

Summary

A Phase 1 safety study of XT-150 in participants with amyotrophic lateral sclerosis (ALS) is described. The trial status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• XT-150

Snippet

Sponsor: Xalud Therapeutics, Inc. | Conditions: Amyotrophic Lateral Sclerosis (ALS) | Phase 1 | Status: NOT_YET_RECRUITING